Efgartigimod shows long-term benefit in Sjögren’s disease study

[Jaybee00]

Efgartigimod shows long-term benefit in Sjögren’s disease study

Efgartigimod was linked to maintained responses and low disease activity for up to 72 weeks in a small Sjögren’s disease study.

sjogrenssyndromenews.com

 

[EndME]

Good for them. If I remember correctly at least one of their other indications (Graves) failed to show positive results.

 

[Arnie Pye]

Efgartigimod - I'm sure there must be some method to the madness when drugs get named but this one takes the cake for being so awful.